NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 342,195 Value ($000) $544 Avg Close — Range —
Q4 2023
Shares 72,174 Value ($000) $62 Avg Close — Range —
Q3 2023
Shares 164,146 Value ($000) $176 Avg Close — Range —
Q2 2023
Shares 346,490 Value ($000) $897 Avg Close — Range —
Q1 2023
Shares 77,389 Value ($000) $316 Avg Close — Range —
Q4 2022
Shares 26,392 Value ($000) $132 Avg Close — Range —
Q3 2022
Shares 294,135 Value ($000) $3,848 Avg Close — Range —
Q2 2022
Shares 227,721 Value ($000) $2,919 Avg Close — Range —
Q1 2022
Shares 157,793 Value ($000) $2,406 Avg Close — Range —
Q4 2021
Shares 694,147 Value ($000) $12,293 Avg Close — Range —
Q3 2021
Shares 758,655 Value ($000) $15,947 Avg Close — Range —
Q2 2021
Shares 708,079 Value ($000) $13,964 Avg Close — Range —
Q1 2021
Shares 380,429 Value ($000) $11,059 Avg Close — Range —
Q4 2020
Shares 166,393 Value ($000) $5,041 Avg Close — Range —
Q3 2020
Shares 41,357 Value ($000) $658 Avg Close — Range —
Q2 2020
Shares 27,953 Value ($000) $551 Avg Close — Range —
Q1 2020
Shares 204,921 Value ($000) $2,527 Avg Close — Range —
Q4 2019
Shares 37,533 Value ($000) $694 Avg Close — Range —
Q3 2019
Shares 23,415 Value ($000) $325 Avg Close — Range —
Q2 2019
Shares 19,715 Value ($000) $289 Avg Close — Range —